Serial Number | 98697887 |
Word Mark | SHAREVAC |
Filing Date | Wednesday, August 14, 2024 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Tuesday, June 3, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Scientific and laboratory apparatus for chemical synthesis; laboratory equipment, namely, mobile laboratory equipped with scientific or laboratory apparatus for chemical synthesis; laboratory equipment, namely, mobile laboratory equipped with scientific or laboratory apparatus for purification and analysis of synthesized compounds; laboratory equipment, namely, mobile device for the synthesis of macromolecules; Scientific and laboratory apparatus for chemical or biological analysis and/or synthesis; laboratory equipment, namely, mobile production station of biological macromolecules for laboratory or and for cell culturing for therapeutic use; Bioreactors for laboratory or and for cell culturing for therapeutic use |
Goods and Services | Bioreactors for use in manufacturing biopharmaceuticals; Filling machines, in particular for use for filling biopharmaceutical compositions into containers; Industry roboters being industrial robots |
Goods and Services | Chemical preparations for medical use, in particular biological macromolecules, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Pharmaceutical preparations namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; Pharmaceuticals preparations and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumour diseases, for the treatment of metabolic disorders and for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations being Nucleic acid macromolecules for in vivo or in vitro expression for human and veterinary use; Dietetic substances adapted for medical use, in particular substances for food supplements; Vaccines |
Pseudo Mark | SHARE VAC |
Goods and Services | Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes |
Goods and Services | Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for the treatment of metabolic disorders; Vaccination services in the nature of administering vaccines to patients |
Goods and Services | Scientific and technological services, namely, and scientific research , in particular for identification, testing and characterisation of biological molecules; scientific research in the nature of pre-clinical and clinical testing of macromolecules for others; Custom synthesis of chemical compounds, in particular biological macromolecules |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 14, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 14, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 007 - Machines and machine tools; motors and engines (except for land vehicles); machine coupling and transmission components (except for land vehicles); agricultural implements other than hand-operated; incubators for eggs. |
US Class Codes | 013, 019, 021, 023, 024, 031, 034, 035 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 14, 2024 |
Primary Code | 007 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 14, 2024 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 14, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, August 14, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | CureVac SE |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Tubingen 72076 DE |
Event Date | Event Description |
Wednesday, August 14, 2024 | NEW APPLICATION ENTERED |
Friday, January 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, February 20, 2025 | ASSIGNED TO EXAMINER |
Tuesday, March 4, 2025 | NON-FINAL ACTION E-MAILED |
Tuesday, March 4, 2025 | NON-FINAL ACTION WRITTEN |
Tuesday, June 3, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, June 3, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, June 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, March 4, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |